[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352040-105":59,"doc-detail-352040-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","bone-loss-osteoporosis-and-skeletal-fragility-hidden-consequences-of-cancer-cachexia","Bone Loss, Osteoporosis, and Skeletal Fragility: Hidden Consequences of Cancer Cachexia","","Cancer cachexia (CC) is a devastating multi-organ syndrome defined by progressive wasting of skeletal muscle and adipose tissue, yet the skeletal system also emerges as a major catabolic target. Evidence shows tumor- and host-derived systemic signals can cause severe bone deterioration even without bone metastases. This review synthesizes data on bone loss, osteopenia, and skeletal decline in non-metastatic CC, arguing bone loss is a hidden but fundamental manifestation. It also emphasizes osteosarcopenia’s prognostic impact and the need for improved screening and targeted therapies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bone-loss-osteoporosis-and-skeletal-fragility-hidden-consequences-of-cancer-cachexia/352040/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bone-loss-osteoporosis-and-skeletal-fragility-hidden-consequences-of-cancer-cachexia/352040.png","ImageObject",300,407,{"name":92,"@type":93},"kopisore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is cancer cachexia (CC), and how is it traditionally defined?","Question",{"text":113,"@type":114},"Cancer cachexia is a multifactorial syndrome characterized by ongoing loss of skeletal muscle mass, usually accompanied by adipose tissue wasting, and it cannot be reversed by nutritional support alone. It reflects a persistent catabolic state and negative energy balance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why is bone deterioration considered an “underappreciated” target in CC?",{"text":118,"@type":114},"The article states that emerging evidence shows the skeletal system is also a major target of the catabolic state. Tumor- and host-derived systemic signals can drive bone loss even in non-metastatic disease.",{"name":120,"@type":111,"acceptedAnswer":121},"How can CC worsen outcomes through combined muscle and bone decline?",{"text":122,"@type":114},"The review highlights that concurrent muscle and bone deterioration (osteosarcopenia) dramatically worsens prognosis across multiple cancers in both adults and children. It also notes that survivors may experience persistent muscle and bone problems after remission, reducing quality of life and outcomes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352040,1790812020,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nBone Loss, Osteoporosis, and Skeletal Fragility: Hidden Consequences of Cancer Cachexia  \nKyle H. Richardson 1,2, Jessica E. Parker 3,4 and Fabrizio Pin 2,3,4,5, *  \nAcademic Editor: Frédéric Lézot  \nReceived: 16 June 2026  \nRevised: 28 July 2026  \nAccepted: 29 July 2026  \nPublished: 1 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 School of Medicine, Indiana University, Indianapolis, IN 46202, USA; [richarkh@iu.edu](richarkh@iu.edu)  \n2 Department of Anatomy, Cell Biology and Physiology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA  \n3 Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, School of Medicine, Indianapolis, IN 46202, USA; [jesepark@iu.edu](jesepark@iu.edu)  \n4 Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN 46202, USA  \n5 Indiana Center for Musculoskeletal Health, School of Medicine, Indiana University, Indianapolis, IN 46202, USA  \n* Correspondence: [fpin@iu.edu](fpin@iu.edu); Tel.: +1-(317)-274-7413  \nAbstract  \nCancer cachexia (CC) is a devastating, multi-organ syndrome historically defined by the progressive wasting of skeletal muscle and adipose tissue. However, emerging evidence suggests that the skeletal system is also a major, yet underappreciated target of this catabolic state. While bone loss in oncology is primarily attributed to skeletal metastasis or cancer treatment-induced bone loss (CTIBL), clinical and preclinical data has increasingly demonstrated that tumor and host-derived systemic signals can drive severe bone deterioration even in non-metastatic disease. This review synthesizes current information available on bone loss, osteopenia, and skeletal decline in the context of CC, with a specific focus on non-metastatic disease. By examining the available literature, we argue that bone loss is a “hidden” yet fundamental systemic manifestation of the cachectic state. Furthermore, we aim to highlight how concurrent muscle and bone deterioration (osteosarcopenia) dramatically worsens prognosis in several different cancers in both the adult and pediatric populations. Ultimately, this review highlights the potential contribution of cancer cachexia to osteoporosis and skeletal fragility, supporting the need for greater clinical awareness, improved musculoskeletal screening, and the development of targeted therapeutic strategies.  \nKeywords: bone loss; BMD; osteoporosis; fracture risk; cancer cachexia  \n1. Introduction  \nCancer cachexia (CC) is a multifactorial and complex syndrome characterized by ongoing loss of skeletal muscle mass, typically accompanied by adipose tissue wasting, that cannot be reversed by nutritional support [1] . Cachexia reflects a persistent catabolic state and negative energy balance caused by anorexia, increased energy expenditure, and profound metabolic reprogramming [2–4] . Depending on tumor type and disease stage, CC affects nearly half of all cancer patients and up to 80% of those with advanced-stage disease [5–7] . It contributes directly to 20–30% of cancer-related deaths and significantly worsens treatment tolerance, functional capacity, quality of life (QoL) and increases mortality [3,5] . Skeletal muscle loss dominates the field of cachexia research. Low muscle mass and sarcopenia are well known to be associated with higher mortality risk, increased chemotherapy toxicity, and reduced QoL in cancer patients [8–11] . However, converging  \nevidence defines cachexia as a multi-organ syndrome. Besides skeletal muscle and white adipose tissue, cachexia involves tissues and organs such as liver, heart, brain, gut, immune system and bone, disrupting energy metabolism, endocrine signaling, and immune homeostasis across the whole organism [4,5,12,13] . These organs are now recognized as active endocrine tissues that communica","cbCaimcPktlSv5FA","https://ap.wps.com/l/cbCaimcPktlSv5FA","pdf",1674802,"English","# Abstract\n# 1. Introduction","[{\"question\":\"What is cancer cachexia (CC), and how is it traditionally defined?\",\"answer\":\"Cancer cachexia is a multifactorial syndrome characterized by ongoing loss of skeletal muscle mass, usually accompanied by adipose tissue wasting, and it cannot be reversed by nutritional support alone. It reflects a persistent catabolic state and negative energy balance.\"},{\"question\":\"Why is bone deterioration considered an “underappreciated” target in CC?\",\"answer\":\"The article states that emerging evidence shows the skeletal system is also a major target of the catabolic state. Tumor- and host-derived systemic signals can drive bone loss even in non-metastatic disease.\"},{\"question\":\"How can CC worsen outcomes through combined muscle and bone decline?\",\"answer\":\"The review highlights that concurrent muscle and bone deterioration (osteosarcopenia) dramatically worsens prognosis across multiple cancers in both adults and children. It also notes that survivors may experience persistent muscle and bone problems after remission, reducing quality of life and outcomes.\"}]","Bone Loss, Osteoporosis, and Skeletal Fragility: Hidden Consequences of Cancer Cachexia | PDF",1790097333,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f37ca9e6a456b9fb97b0ef2090d0996.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a680953effd52202ddc92a7159179e83.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7f4e4df1da6d99115e07c544c1cf37d.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11e9ce43755c608945a692c134f580c3.webp",980,1385]